Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BREXPIPRAZOLE vs BRIMONIDINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BREXPIPRAZOLE vs BRIMONIDINE: Safety Overview

Metric BREXPIPRAZOLE BRIMONIDINE
Total FAERS Reports 13,270 11,830
Deaths Reported 673 59
Death Rate 5.1% 0.5%
Hospitalizations 1,269 367
Average Patient Age 50.5 yrs 62.4 yrs
% Female Patients 69.0% 70.9%
FDA Approval Date Aug 11, 2022 Apr 19, 2024
Manufacturer Otsuka America Pharmaceutical, Inc. Somerset Therapeutics, LLC
Route ORAL OPHTHALMIC
Marketing Status Prescription Discontinued